High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo

BMC Nephrology

Volumn 10, Issue 1, 2009, Pages

  Sumaili, Ernest K ^a,c   Cohen, Eric P ^b   Zinga, Chantal V ^a   Krzesinski, Jean Marie ^c   Pakasa, Nestor M ^a   Nseka, Nazaire M ^a  

^a UNIVERSITY OF KINSHASA   (Congo)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CHRONIC KIDNEY DISEASE; CONGO; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIMARY HEALTH CARE; PROTEINURIA; RANDOM SAMPLE; RISK FACTOR; SCREENING; ADOLESCENT; BLOOD; CHRONIC DISEASE; DEMOCRATIC REPUBLIC CONGO; KIDNEY DISEASE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CREATININE; CROSS-SECTIONAL STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; DIABETES COMPLICATIONS; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 69049111040     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-10-18     Document Type: Article

References (46)

1. The global challenge of chronic kidney disease. M El Nahas, Kidney Int 2005 68 6 2918 2929 10.1111/j.1523-1755.2005.00774.x 16316385
2. High prevalence of chronic kidney disease in Iran: a large population-based study. F Hosseinpanah F Kasraei AA Nassiri F Azizi, BMC Public Health 2009 9 1 44 19183493 10.1186/1471-2458-9-44
3. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. FA Arogundade RS Barsoum, Am J Kidney Dis 2008 51 3 515 523 10.1053/j.ajkd.2007.12.006 18295068
4. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. EK Sumaili JM Krzesinski CV Zinga EP Cohen P Delanaye SM Munyanga NM Nseka, Nephrol Dial Transplant 2009 24 1 117 122 10.1093/ndt/gfn469 18715963
5. The nephrotic syndrome in the Democratic Republic of Congo. NM Pakasa EK Sumaili, N Engl J Med 2006 354 10 1085 1086 10.1056/NEJMc052696 16525148
6. How to tackle the avalanche of chronic kidney disease in Sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. JM Krzesinski EK Sumaili E Cohen, Nephrol Dial Transplant 2007 22 2 332 335 10.1093/ndt/gfl494 17035376
7. Prevention of chronic kidney and vascular disease: toward global health equity - the Bellagio 2004 Declaration. JH Dirks D de Zeeuw SK Agarwal RC Atkins R Correa-Rotter G D'Amico PH Bennett M El Nahas RH Valdes D Kaseje et al., Kidney Int Suppl 2005 98 S1 6 10.1111/j.1523-1755.2005.09800.x
8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993 329 14 977 986 10.1056/NEJM199309303291401 8366922
9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 9131 837 853 10.1016/S0140-6736(98)07019-6 9742976
10. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. P Ruggenenti A Perna G Remuzzi, J Am Soc Nephrol 2001 12 12 2832 2837 11729254
11. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving G Remuzzi SM Snapinn Z Zhang S Shahinfar, N Engl J Med 2001 345 12 861 869 10.1056/NEJMoa011161 11565518
12. Chronic kidney disease in the developing world. RS Barsoum, N Engl J Med 2006 354 10 997 999 10.1056/NEJMp058318 16525136
13. Screening for proteinuria in US adults: a cost-effectiveness analysis. LE Boulware BG Jaar ME Tarver-Carr FL Brancati NR Powe, JAMA 2003 290 23 3101 3114 10.1001/jama.290.23.3101 14679273
14. Screening for chronic kidney disease: where does Europe go? PE de Jong M van der Velde RT Gansevoort C Zoccali, Clin J Am Soc Nephrol 2008 3 2 616 623 10.2215/CJN.04381007 18287253
15. HIV/AIDS - dominant player in chronic kidney disease. S Naicker TM Han J Fabian, Ethn Dis 2006 16 2 Suppl 2 S2 56 16774012
16. Estimating Glomerular Filtration Rate in Black South Africans by Use the Modification of Diet in Renal Disease and Cockcroft-Gault Equations. HE Van Deventer JA George JE Paiker PJ Becker IJ Katz, Clin Chem 2008 54 7 1197 1202 10.1373/clinchem.2007.099085 18487286
17. Statistique épidemiologie. T Ancelle, Maloine; FR. Paris 2002
18. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr et al., JAMA 2003 289 19 2560 2572 10.1001/jama.289.19.2560 12748199
19. The problem of overweight and obesity 2000: preventing and managing the global epidemic. WHO, Report series 894 Wt. Geneva: WHO 2000 537
20. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. AS Levey J Coresh T Greene LA Stevens YL Zhang S Hendriksen JW Kusek F Van Lente, Ann Intern Med 2006 145 4 247 254 16908915
21. K/DOQI clinical practice guidelines for chronic kidney disease 2002: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 2 Suppl 1 S1 266 11904577
22. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. RD Toto KA Kirk J Coresh C Jones L Appel J Wright V Campese B Olutade L Agodoa, J Am Soc Nephrol 1997 8 2 279 287 9048347
23. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). WW Brown RM Peters SE Ohmit WF Keane A Collins SC Chen K King MJ Klag DA Molony JM Flack, Am J Kidney Dis 2003 42 1 22 35 10.1016/S0272-6386(03)00405-0 12830453
24. Screening for CKD with eGFR: doubts and dangers. RJ Glassock C Winearls, Clin J Am Soc Nephrol 2008 3 5 1563 1568 10.2215/CJN.00960208 18667744
25. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. SI Hallan K Dahl CM Oien DC Grootendorst A Aasberg J Holmen FW Dekker, BMJ 2006 333 7577 1047 17062598 10.1136/bmj.39001.657755.BE
26. Proteinuria screening using sulfosalicylic acid: advantages of the method for the monitoring of prenatal consultations in West Africa. CF Robert A Mauris P Bouvier A Rougemont, Soz Praventivmed 1995 40 1 44 49 10.1007/BF01615661 7900435
27. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. T Konta Z Hao S Takasaki H Abiko M Ishikawa T Takahashi A Ikeda K Ichikawa T Kato S Kawata et al., Clin Exp Nephrol 2007 11 1 51 55 10.1007/s10157-006-0458-z 17384998
28. Urinary albumin excretion as a predictor of the development of hypertension in the general population. AH Brantsma SJ Bakker D de Zeeuw PE de Jong RT Gansevoort, J Am Soc Nephrol 2006 17 2 331 335 16434504
29. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. AH Brantsma SJ Bakker HL Hillege D de Zeeuw PE de Jong RT Gansevoort, Diabetes Care 2005 28 10 2525 2530 10.2337/diacare.28.10.2525 16186291
30. Proteinuria and the risk of developing end-stage renal disease. K Iseki Y Ikemiya C Iseki S Takishita, Kidney Int 2003 63 4 1468 1474 10.1046/j.1523-1755.2003.00868.x 12631363
31. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. B Kestenbaum KD Rudser IH de Boer CA Peralta LF Freid MG Shlipak W Palmas C Stehman-Breen DS Siscovick, Ann Intern Med 2008 148 501 508 18378946
32. Chronic kidney disease-the promise and the perils. WG Couser, J Am Soc Nephrol 2007 18 2803 2805 10.1681/ASN.2007080964 17942947
33. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. AS Levey R Atkins J Coresh EP Cohen AJ Collins KU Eckardt ME Nahas BL Jaber M Jadoul A Levin et al., Kidney Int 2007 72 3 247 259 10.1038/sj.ki. 5002343 17568785
34. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). J Coresh GL Wei G McQuillan FL Brancati AS Levey C Jones MJ Klag, Arch Intern Med 2001 161 9 1207 1216 10.1001/archinte.161.9. 1207 11343443
35. Evaluation of the modification of diet in renal disease study equation in a large diverse population. LA Stevens J Coresh HI Feldman T Greene JP Lash RG Nelson M Rahman AE Deysher YL Zhang CH Schmid et al., J Am Soc Nephrol 2007 18 10 2749 2757 10.1681/ASN.2007020199 17855641
36. End-stage renal disease in the USA: data from the United States Renal Data System. LY Agodoa CA Jones PJ Held, Am J Nephrol 1996 16 1 7 16 10.1159/000168965 8719761
37. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JT Wright Jr G Bakris T Greene LY Agodoa LJ Appel J Charleston D Cheek JG Douglas-Baltimore J Gassman R Glassock et al., JAMA 2002 288 19 2421 2431 10.1001/jama.288.19.2421 12435255
38. Antiretroviral therapy improves renal function among HIV-infected Ugandans. PJ Peters DM Moore J Mermin JT Brooks R Downing W Were A Kigozi K Buchacz PJ Weidle, Kidney Int 2008 74 7 925 929 10.1038/ki.2008.305 18614998
39. Chronic kidney disease in human immunodeficiency virus infection. J Fabian I Katz T Gerntholtz S Goetsch S Naicker, Panminerva Med 2007 49 2 51 66 17625482
40. Human immunodeficiency virus-associated nephropathy. East is east and west is west? MH Humphreys, Arch Intern Med 1990 150 2 253 255 10.1001/archinte.150.2.253 2405796
41. Absence of HIV-associated nephropathy in Ethiopians. DM Behar LI Shlush C Maor M Lorber K Skorecki, Am J Kidney Dis 2006 47 1 88 94 10.1053/j.ajkd.2005. 09.023 16377389
42. HIV-associated nephropathy in African Americans. JB Kopp C Winkler, Kidney Int Suppl 2003 83 S43 49 10.1046/j.1523-1755.63.s83.10.x 12864874
43. Risk factors for proteinuria in a large, multiracial, southeast Asian population. SP Ramirez W McClellan FK Port SI Hsu, J Am Soc Nephrol 2002 13 7 1907 1917 10.1097/01.ASN.0000018406.20282.C8 12089388
44. Kidney injury from alternative medicines. CR Colson ME De Broe, Adv Chronic Kidney Dis 2005 12 3 261 275 10.1016/j.ackd.2005.03.006 16010641
45. Screening for proteinuria and chronic kidney disease risk factors in Kinshasa: a World Kidney Day 2007 study. EK Sumaili NM Nseka FB Lepira JM Krzesinski JR Makulo JB Bukabau JB Nkoy VM Mokoli MM Longokolo JA Owandjalola et al., Nephron Clin Pract 2008 110 4 c220 228 10.1159/000167869 18974653
46. Should active recruitment of health workers from Sub-Saharan Africa be viewed as a crime? EJ Mills WA Schabas J Volmink R Walker N Ford E Katabira A Anema M Joffres P Cahn J Montaner, Lancet 2008 371 9613 685 688 10.1016/S0140-6736(08)60308-6 18295027